223 related articles for article (PubMed ID: 15351176)
1. The trials of anakinra.
Burls A; Jobanputra P
Lancet; 2004 Sep 4-10; 364(9437):827-8. PubMed ID: 15351176
[No Abstract] [Full Text] [Related]
2. [Anakinra for therapy of rheumatoid arthritis].
Tomoo T; Sumida T
Nihon Rinsho; 2005 Jan; 63 Suppl 1():534-7. PubMed ID: 15799413
[No Abstract] [Full Text] [Related]
3. Anakinra shows promise for treating patients with rheumatoid arthritis.
McIntosh T; Freeman TR
J Am Pharm Assoc (Wash); 2002; 42(4):660-2. PubMed ID: 12150367
[No Abstract] [Full Text] [Related]
4. New drugs for rheumatoid arthritis.
Olsen NJ; Stein CM
N Engl J Med; 2004 May; 350(21):2167-79. PubMed ID: 15152062
[No Abstract] [Full Text] [Related]
5. Etanercept and methotrexate in rheumatoid arthritis.
Malgarini RB; Pimpinella G
Lancet; 2004 May; 363(9422):1733; author reply 1733. PubMed ID: 15158641
[No Abstract] [Full Text] [Related]
6. Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial.
Fleischmann RM; Schechtman J; Bennett R; Handel ML; Burmester GR; Tesser J; Modafferi D; Poulakos J; Sun G
Arthritis Rheum; 2003 Apr; 48(4):927-34. PubMed ID: 12687534
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.
Genovese MC; Cohen S; Moreland L; Lium D; Robbins S; Newmark R; Bekker P;
Arthritis Rheum; 2004 May; 50(5):1412-9. PubMed ID: 15146410
[TBL] [Abstract][Full Text] [Related]
8. The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.
Cohen SB
Rheum Dis Clin North Am; 2004 May; 30(2):365-80, vii. PubMed ID: 15172046
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic use of "biologics" in inflammatory joint and spinal diseases].
Seitz M
Ther Umsch; 2002 Oct; 59(10):535-43. PubMed ID: 12428439
[TBL] [Abstract][Full Text] [Related]
10. Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis.
Tesser J; Fleischmann R; Dore R; Bennett R; Solinger A; Joh T; Modafferi D; Schechtman J;
J Rheumatol; 2004 Apr; 31(4):649-54. PubMed ID: 15088288
[TBL] [Abstract][Full Text] [Related]
11. [Recommendations of the Deutschen Gesellschaft für Rheumatologie on therapy of rheumatoid arthritis with the interleukin-1-receptor-antagonist Akakinra (KINERET)].
Manger B;
Z Rheumatol; 2002 Dec; 61(6):698-700. PubMed ID: 12491134
[No Abstract] [Full Text] [Related]
12. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.
Cohen SB; Moreland LW; Cush JJ; Greenwald MW; Block S; Shergy WJ; Hanrahan PS; Kraishi MM; Patel A; Sun G; Bear MB;
Ann Rheum Dis; 2004 Sep; 63(9):1062-8. PubMed ID: 15082469
[TBL] [Abstract][Full Text] [Related]
13. Anakinra: new preparation. Weakly effective in rheumatoid arthritis.
Prescrire Int; 2004 Apr; 13(70):43-5. PubMed ID: 15148945
[TBL] [Abstract][Full Text] [Related]
14. Anakinra (interleukin-1 receptor antagonist) has positive effects on function and quality of life in patients with rheumatoid arthritis.
Kavanaugh A
Adv Ther; 2006; 23(2):208-17. PubMed ID: 16751154
[TBL] [Abstract][Full Text] [Related]
15. Safety of anakinra, a recombinant interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis and comparison to anti-TNF-alpha agents.
Fleishmann RM
Clin Exp Rheumatol; 2002; 20(5 Suppl 27):S35-41. PubMed ID: 14989428
[TBL] [Abstract][Full Text] [Related]
16. [Anakinra in the treatment of rheumatoid arthritis].
Loft AG; Tarp U; Thomsen BS
Ugeskr Laeger; 2003 Sep; 165(39):3720-4. PubMed ID: 14558384
[No Abstract] [Full Text] [Related]
17. Anakinra: a review of its use in the management of rheumatoid arthritis.
Waugh J; Perry CM
BioDrugs; 2005; 19(3):189-202. PubMed ID: 15984903
[TBL] [Abstract][Full Text] [Related]
18. [The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis].
Riente L
Reumatismo; 2004; 56(1 Suppl 1):74-9. PubMed ID: 15201943
[TBL] [Abstract][Full Text] [Related]
19. [Biological agents for therapy of rheumatoid arthritis--overview].
Takeuchi T
Nihon Rinsho; 2005 Jan; 63 Suppl 1():513-6. PubMed ID: 15799409
[No Abstract] [Full Text] [Related]
20. [Anti-TNF-alpha-treatment of arthritis--4-year follow-up].
Petri A; Dreyer L; Danneskiold-Samsøe B; Terslev L; Bliddal H
Ugeskr Laeger; 2003 Nov; 165(48):4649-52. PubMed ID: 14677465
[No Abstract] [Full Text] [Related]
[Next] [New Search]
